MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN) announced it has completed enrollment for the Phase 3 liMeliGhT clinical trial evaluating OCU400, a gene therapy candidate for retinitis pigmentosa, a group ...

Biotechnology firm Ocugen has successfully completed patient enrollment for its pivotal Phase 3 clinical trial, known as liMeliGhT, marking a significant step f ...

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact ...

By Tahna Weston tahna.weston@antiguaobserver.com A veteran optometrist is sounding the alarm about the limitations of free public eye screenings, cautioning that attending one could leave a person ...